OMICS International

International Conferences

Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series Ltd: World’s leading Event Organizer

 

Medicine for HIV


OMICS International hosted 1 national symposium on Key word Medicines for HIV

Medicines for HIV and AIDS are used to decrease the amount of HIV in the body and to strengthen the immune system. HIV is treated using a combination of medicines to fight HIV infection. This is called antiretroviral therapy (ART). ART isn’t a cure, but it can control the virus so that you can live a longer, healthier life and reduce the risk of transmitting HIV to others. ART involves taking a combination of HIV medicines (called an HIV regimen) every day, exactly as prescribed.

OMICS International 1000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies  and Publishes 700+ Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members. The conference series website will provide you list and details about the conference organize worldwide.

IV virus is from a subgroup of retro virus called lentivirus. There are two types of HIV virus discovered and they both cause 'Acquired Immuno Deficiency Syndrome'. AIDS is a condition where one's immune system starts to degrade with time causing other infectious diseases and cancer to prevail in the body. AIDS is life threatening and the average survival duration without treatment would be 9-11 years after infection. HIV is transferred from one person to another by exchange of body fluids which includes transfer of blood, semen, vaginal fluid, pre-ejaculate, or breast milk. HIV infects vital cells in the human immune system. It attacks helper T cells (specifically CD4+ T cells), macrophages, and dendritic cells. HIV infection eventually leads to very low levels of CD4+ T cells. As the CD4+ T cell numbers decline below a critical level, cell-mediated immunity is lost, and then the body becomes progressively more and more susceptible to opportunistic infections. Medications for HIV or AIDS are used to reduce the quantity of HIV in the body and to strengthen up the immune system. There are six types of HIV medications. Most commonly, three different types are taken together, also known as combination therapy. It is very essential to take them exactly as prescribed to maintain success, and to help to prevent the virus from becoming resistant to the medicines. These medicines are usually consumed for the entire lifetime.

There are five major types of medicines: Reverse transcriptase inhibitors - abacavir, didanosine, emtricitabine, lamivudine, stavudine, and tenofovir, Protease inhibitors - atazanavir, darunavir, fosamprenavir, indinavir, lopinavir, nelfinavir, ritonavir, saquinavir, and tipranavir, Integrase inhibitors – raltegravir, Fusion inhibitors – enfuvirtide and CCR5 antagonists - maraviroc.

These medicines do no cure people the infection is still there in the body. They can still spread HIV to others through unprotected sex and needle sharing. According to the recent research in the field of medicine the first complete treatment for AIDS that is taken once a day as a single pill is expected to be available soon. The new drug is a combination of drugs already on the market — Sustiva, by Bristol-Myers Squibb, and Truvada, by Gilead Sciences. HIV statistics for the end of 2011 indicate that around 34 million people are living with HIV. Each year around 2.5 million more people become infected with HIV and 1.7 million die of AIDS. Although HIV and AIDS are found in all parts of the world, some areas are more afflicted than others.

Sales of antiretroviral drugs in America and the five biggest European markets reached $13.3 billion in 2011, according to Datamonitor, a research outfit (see chart 2). The market is as unusual as it is large, both buoyed by government support and worryingly dependent on it. The past decade has brought fancier medicine in rich countries and copious aid for poor ones. But the war is far from won.Publicly funded research has played a larger role in developing drugs for HIV than for other diseases. A study published last year in Health Affairs found that HIV drugs were three times as likely to involve a patent from the public sector. HIV also has special status among regulators. America's Food and Drug Administration (FDA) created a faster way to review HIV drugs, allowing them on the market before the most expensive stage of clinical trials.

Relevant conferences

  1. 4th HIV/AIDS, STDs, & STIs Conference,                                                    November 30-December 02, 2015 Hilton Atlanta Airport, Atlanta, USA
  2. 4th Immunology Conference, September 28-30, 2015 Houston, Texas, USA
  3. 2nd Infectious Diseases Conference, August 25-27, 2016 Philadelphia, USA
  4. 2nd Influenza Conference, September 12-14, 2016 Berlin, Germany
  5. Infection Prevention and Control Conference, Aug 1-2, 2016 Frankfurt, Germany
  6. 2nd Innate Immunity Conference, July 21-22, 2016 Berlin, Germany
  7. 2nd Parasitology Conference, August 01-03, 2016 Manchester, UK
  8. 2nd Antibodies Conference, July 14-15, 2016 Philadelphia, USA
  9. 2nd Neuroimmunology & Therapeutics Conference,                                        March 31-April 02, 2016 Atlanta, USA
  10.  7th Vaccines & Vaccination Conference, September 28-30, 2015 Dubai, UAE
  11. 9th Vaccines & Vaccination Conference,                                                           November 30-December 02, 2015 San Francisco, USA
  12. 10th Vaccines & Vaccination Conference, June 16-18, 2016 Rome, Italy
  13. 13th Vaccines & Vaccination Conference,                                                         November 10-12, 2016 Melbourne, Australia
  14. 2nd Applied Microbiology Conference,                                                             October 31-November 02, 2016 Istanbul, Turkey
  15. 6th Cell & Stem Cells Research Conference,                                                      February 29-March 02, 2016 Philadelphia, USA
  16.  2nd Antibiotics Conference October 03-05, 2016 London, UK
  17. 5th Cancer Therapy Conference, September 28-30, 2015 Atlanta, Georgia, USA
  18. Beneficial Microbes: Food, Pharma, Aqua & Beverages Industry Conference, September 23-25, 2016 Phoenix, USA
  19. 4th Bacteriology and Infectious Diseases Conference,                                        May 16-18, 2016 San Antonio, USA
  20. Allergy Conference, March 29-30, 2016 Valencia, Spain
  21. United States Conference on AIDS
  22. 2015 National HIV Prevention Conference
  23. The North American Housing and HIV/AIDS Research Summit VIII
  24. World STI & HIV Congress joint with the Australasian HIV & AIDS Conference
  25. 15th European AIDS Conference
  26. 7th International Workshop on HIV Persistence during Therapy
  27. World STI & HIV Congress
  28. 17th Bangkok International Symposium on HIV Medicine
  29. World STI & HIV Congress
  30. 7th International Workshop on HIV Persistence, Reservoirs and Cure
  31. 27th Annual National Conference on Social Work and HIV/AIDS
  32. 21st International AIDS Conference

Relevant Societies

  1. Global HIV/AIDS Organizations - AIDS.gov
  2. AIDS Healthcare Foundation
  3. HIV/AIDS - American Sexual Health Association
  4. HIVMA: HIV Medicine Association
  5. IAPAC - International Association of Providers of AIDS Care
  6. APHA: HIV/AIDS - American Public Health Association
  7. Australian Federation of AIDS Organisations
  8. HIV/AIDS Organizations | AIDSTruth.org
  9. The Elizabeth Glaser Pediatric AIDS Foundation
  10. The Forum for Collaborative HIV Research
  11. The Elton John AIDS Foundation

Relevant Companies

  1. Bristol-Myers Squibb
  2. Pfizer
  3. GlaxoSmithKline plc.
  4. Gilead
  5. Astellas
  6. Bayer's Pharma
  7. Cipla
  8. Merck & Co.
  9. Natco Pharma
  10. Novartis
  11. Novo Nordisk
  12. Pfizer
  13. Roche
  14. Sunpharma
  15. Sanofi
  16. Johnson & Johnson
  17. Sanofi
  18. GlaxoSmithKline
  19. Bayer HealthCare
  20. AstraZeneca
  21. Eli Lilly

This page will be updated regularly.

This page was last updated on 09th Sep, 2015

Conferenceseries Destinations

Contact Us

Medical Conferences
Jessie Grace
jessie.grace@conferenceseries.com
1-702-508-5200 Ext:8031, 8041

Pharmaceutical Conferences
Badoni Victor
badoni.victor@conferenceseries.com
1-702-508-5200 Ext:8045, 8047

Immunology & Microbiology Conferences
Walker Smith
walker.smith@conferenceseries.com
1-702-508-5200 Ext:8031

Cancer Conferences
Raul Cliff
raul.cliff@conferenceseries.com
1-702-508-5200 Ext:8039

Nursing and Healthcare Conferences
Jennifer Leny
jennifer.leny@conferenceseries.com
1-702-508-5200 Ext:8044

Diabetes Conferences
Stanley knight
stanley.knight@conferenceseries.com
1-702-508-5200 Ext:8040

Neuroscience Conferences
Sandeep Kumar
sandeep@conferenceseries.com
1-702-508-5200 Ext:8034

Dental Conferences
Raul Cliff
raul.cliff@conferenceseries.com
1-702-508-5200 Ext:8039

Clinical and Biochemistry Conferences
Rohit Casper
rohit.casper@conferenceseries.com
1-702-508-5200 Ext:8033

Biotechnology Conferences
Ravi Vittal
ravi.vittal@conferenceseries.com
1-702-508-5200 Ext:8031, 8037

Material Science Conferences
Lucy Grey
lucygrey@conferenceseries.com
1-702-508-5200 Ext:8035

Genetics & Mol Biology Conferences
Stephen Bruce
stephen.bruce@conferenceseries.com
1-702-508-5200 Ext:8038

Engineering Conferences
Dolly A
dolly@conferenceseries.com
+1-702-508-5200 Ext:8051

Program Enquiries
Symposia/Workshops
Sponsorships
Media Partners | Advertising